RA Capital Management, L.P. 13D/13G Filings for Crinetics Pharmaceuticals, Inc. (CRNX)

RA Capital Management, L.P. 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:39 pm
Sale
2020-12-3113GCrinetics Pharmaceuticals, Inc.
CRNX
RA Capital Management, L.P.564,102
1.700%
-1,311,107decrease
(-69.92%)
Filing